Physician profile
Chase Hobbs
NPI 1780248732
$131,062.68
in general payments reported to CMS, 2019-2025
16 companies · $5,338 in 2025
The $5,338 reported for 2025 was more than what 83% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.54 · 2021: $84.31 · 2022: $1,442 · 2023: $1,499 · 2024: $123K · 2025: $5,338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $120K · Food and Beverage: $7,159 · Travel and Lodging: $2,066 · Education: $240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $120,000.00 |
| Food and Beverage | $7,159.47 |
| Travel and Lodging | $2,065.77 |
| Education | $240.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linkbio Corp | $120,000.00 | 2024 | |
| Stryker Corporation | $4,017.68 | 2022-2025 | Mako, Blueprint Patient Specific Instrumentation, Gamma |
| Medacta USA, INC. | $2,542.55 | 2025 | Gmk Sphere, Amistem |
| Titan Surgical Group, LLC | $1,523.86 | 2022-2024 | |
| Zimmer Biomet Holdings, INC. | $1,427.85 | 2023-2025 | Avenir, Persona, Mymobility Platform |
| Depuy Synthes Sales INC. | $546.42 | 2024-2025 | Attune, Actis |
| Medical Device Business Services, INC. | $348.42 | 2024-2025 | Velys |
| Smith+Nephew, INC. | $192.39 | 2025 | Legion Revision, Polarstem, Redapt |
| Innovation Technologies INC | $106.14 | 2023 | Irrisept |
| Skeletal Dynamics INC | $103.08 | 2024-2025 | Implate, Align, Geminus |
| Microport Orthopedics INC | $73.18 | 2021 | |
| Boston Scientific Corporation | $70.54 | 2019 | |
| Biocomposites INC | $56.34 | 2024-2025 | Stimulan |
| Vertex Pharmaceuticals Incorporated | $23.73 | 2025 | |
| Becton, Dickinson and Company | $19.37 | 2025 | Arista |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $11.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chase Hobbs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.